advance

Foundation Medicine and Day One Biopharmaceuticals Announce Global Collaboration to Advance Pediatric Cancer Care

Foundation Medicine and Day One Biopharmaceuticals Announce Global Collaboration to Advance Pediatric Cancer Care

CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Foundation Medicine, Inc., a pioneer in cancer molecular profiling, and Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with cancer. life-threatening diseases, today announced a collaboration to develop FoundationOne®CDx as a Companion Diagnostic for Day …

Foundation Medicine and Day One Biopharmaceuticals Announce Global Collaboration to Advance Pediatric Cancer Care Read More »

Study shows teens with cancer can benefit from advance care discussions |  MinnPost

Study shows teens with cancer can benefit from advance care discussions | MinnPost

As a critical care pediatrician, Dr. Jennifer Needle has treated a number of adolescents and young adults with cancer. These young people have come to intensive care because they are experiencing life-threatening complications from their cancer treatment. At times, Needle and his fellow physicians have had to engage in serious end-of-life discussions with these patients …

Study shows teens with cancer can benefit from advance care discussions | MinnPost Read More »